Thrombotic Thrombocytopenic Purpura-Hemolytic Uremic Syndrome (TTP-HUS) in Adults Following a Prodrome of Bloody Diarrhea.

Blood ◽  
2004 ◽  
Vol 104 (11) ◽  
pp. 859-859
Author(s):  
Qurana F. Lewis ◽  
Deirdra R. Terrell ◽  
Bernhard Lammle ◽  
Johanna Kremer-Hovinga ◽  
James N. George ◽  
...  

Abstract Diarrhea, often bloody diarrhea caused by infection with E. coli 0157:H7, is the prodrome for typical HUS in children. In adults, HUS has been reported following epidemics of enteric infections, however the frequency and clinical features of sporadic HUS or TTP in adults following a prodrome of bloody diarrhea have not been characterized. In the Oklahoma TTP-HUS Registry, January 1, 1989 to December 31, 2003, 19 (6%) of 301 consecutive patients had a prodrome of bloody diarrhea. The 19 cases were separated by time and location, indicating no common source outbreak. 5/10 patients who were appropriately tested had positive stool cultures for E. coli O157:H7. Although more cases (12/19, 63%) occurred in warm months, April–September, a seasonal difference was not significant (p= 0.25). We compared the clinical features of these 19 patients to the 119 patients who had no apparent etiologies or associated conditions and were therefore defined as idiopathic TTP-HUS. Bloody Diarrhea Idiopathic p-value (n=19) (n=119) Median values are presented for continuous data. Laboratory data: most abnormal value at diagnosis of TTP-HUS ± 7 days Age (years) 59 48 0.109 Race (% Black) 5% 25% 0.073 Gender (% female) 79% 74% 0.781 Obesity (BMI≥30 kg/m2) 21% 40% 0.120 Severe neurologic abnormalities 63% 49% 0.243 Platelet count 26 13 0.010 Hematocrit 22 22 0.931 LDH 1410 1305 0.115 Acute renal failure 68% 29% <0.001 Response to PE 84% 82% 1.000 ADAMTS13 deficiency (<5%) 0% (0/13) 30% (20/67) 0.031 Death 32% 19% 0.233 Relapse in 30 day survivors 0% 20% 0.119 Although women predominated in both groups, 18/19 patients with a prodrome of bloody diarrhea were White, consistent with the predominance of White subjects among children with diarrhea-associated HUS, but distinct from the significantly higher incidence of Blacks among adult patients with idiopathic TTP-HUS (compared to the incidence among other races, p<0.0001). 3 patients with a prodrome of bloody diarrhea never had an abnormal serum creatinine, therefore the term TTP-HUS, rather than HUS, may better describe these patients. The only significant differences in presenting features and outcomes were the severity of thrombocytopenia, the relative frequency of acute renal failure, and the relative frequency of severe ADAMTS13 deficiency (<5% activity). ADAMTS13 activity was measured in 13 of the 19 patients with a prodrome of bloody diarrhea (median 50%, range 5–100%). We conclude that there is a continuous occurrence of TTP-HUS in adults preceded by a prodrome of bloody diarrhea, presumably related to Shiga toxin-producing enteric infections, even in the absence of recognized outbreaks. Plasma exchange is an appropriate treatment for adult patients with a prodrome of bloody diarrhea since they cannot be accurately distinguished from patients with idiopathic TTP, they have a high mortality rate, and they apparently respond to plasma exchange treatment.

Blood ◽  
2007 ◽  
Vol 110 (11) ◽  
pp. 1317-1317
Author(s):  
Loan Nguyen ◽  
Charity A. Karpac ◽  
Johanna A. Kremer Hovinga ◽  
Bernhard Lämmle ◽  
Deirdra R. Terrell ◽  
...  

Abstract The frequency, presenting features and clinical outcomes of sporadic TTP-HUS following a prodrome of bloody diarrhea in adults are not described. The Oklahoma TTP-HUS Registry enrolled 237 consecutive patients over age 18 years with their first episode of clinically diagnosed TTP from 11-13-1995 (the date of our initial ADAMTS13 measurement) to 12-31-2006 for whom plasma exchange treatment (PEX) was requested. ADAMTS13 activity was measured on 218 (92%) patients immediately before their first PEX. 16 (7%) of these 218 patients presented with a prodrome of acute bloody diarrhea. 42 (19%) patients had ADAMTS13 activity <10%. 2 patients who presented with acute bloody diarrhea had ADAMTS13 activity <10%; they are analyzed with the bloody diarrhea patients; ADAMTS13 activity in the remaining 14 patients was 40–100%. Children with typical HUS are not usually treated with PEX and therefore are not all included in the Registry. Data on children were retrieved from the Children’s Hospital of Oklahoma for 2002–2006 to identify all children with typical HUS; 28 children were identified. E. coli O157:H7 infection was identified in 5 adults (of 12 tested) and 19 children (of 25 tested). No source for E. coli O157:H7 infection was identified. There were no case clusters except for one family with 2 affected children. In 2 of the adults with bloody diarrhea, a colectomy was performed before the correct diagnosis was made. Patient characteristics Adults, bloody diarrhea prodrome (n=16) Adults, ADAMTS13 deficiency (n=40) Children, diarrhea prodrome (n=28) * p≤0.05 for adult bloody diarrhea prodrome compared to adult ADAMTS13 deficient patients; ** p≤0.05 for adult bloody diarrhea prodrome compared to children bloody diarrhea prodrome patients; †seizure, stroke, coma, focal abnormalities anytime during the course; ‡most abnormal values on the day of diagnosis ± 7 days; median §defined by ↑ Cr ≥ 0.5 mg/dL x 2 days or Cr ≥4.0 and dialysis. Age (years, median) 58 40* 3.8** Female (%) 80% 81% 64% Race (% white) 94% 53%* 75% Severe neurologic abnormalities† 63% 45% 7%** Platelet count (/μL)‡ 24,000 10,000* 34,000 Hematocrit (%)‡ 22 21 18** LDH (/UL) ‡ 1410 1431 1161 Creatinine (mg/dL)‡ 2.7 1.0* 3.7 Acute renal failure§ 50% 8%* 57% Response to PEX (%) 81% 85% NA Dialysis (%) 31% 3%* 57% Death (30 days) 31% 15% 0%** Relapse (%) 0% (0/10) 38% (13/34)* NA Conclusions: TTP-HUS following bloody diarrhea is an endemic, sporadic disorder among adults that is less common and less familiar than in children. Distinct from children, adults with bloody diarrhea have a higher frequency of severe neurologic abnormalities and death; distinct from adults with severe ADAMTS13 deficiency, adults with bloody diarrhea are primarily white, have a higher frequency of acute renal failure, and have not relapsed. Although the role of PEX in the recovery of adult patients presenting with bloody diarrhea is unclear, PEX may be appropriate initial treatment since the mortality is high, many patients appear to respond, and patients with severe ADAMTS13 deficiency may also present with bloody diarrhea apparently caused by intestinal ischemia.


Blood ◽  
2013 ◽  
Vol 122 (21) ◽  
pp. 4752-4752
Author(s):  
Shruti Chaturvedi ◽  
Keith R. McCrae ◽  
Desiree Carcioppolo

Background and Objective Thrombotic thrombocytopenic purpura is often associated with a severe congenital or antibody mediated deficiency of ADAMTS13. The wider availability of the ADAMTS13 activity assay has led to it being used to aid in making treatment decisions. However, a proportion of patients with clinically diagnosed TTP who respond well to plasma exchange do not have severe ADAMTS13 deficiency. We studied a cohort of 57 patients with TTP to compare the presenting features and clinical outcomes of patients with and without severe ADAMTS13 deficiency. Methods We identified a cohort of 57 patients treated for TTP at the Cleveland Clinic between 2000 and 2012 who underwent testing for ADAMTS13 activity prior to transfusion of blood products or initiation of plasma exchange. Clinical and laboratory data were gathered from their medical records. Fisher exact test was used to compare categorical variables and the T-test was used to compare continuous variables between patients with and without severe ADAMTS13 deficiency defined as undetectable (<5%) activity. Results Thirty six (63%) of 57 patients had severe ADAMTS13 deficiency while the remaining 21 (37%) has ADAMTS13 activity ranging from 8% to 56%. Of the 36 patients with severe ADAMTS13 deficiency, 28 had idiopathic TTP while 8 had secondary TTP. For patients with detectable ADAMTS13 levels there were 12 and 9 patients with idiopathic and secondary TTP respectively. There was no significant difference in the clinical setting (idiopathic versus secondary TTP) (p=100), age (p=0.190) or sex distribution (p=0.362) between patients with and without severe ADAMTS13 deficiency. Patients with and without severe ADAMTS13 deficiency had heterogeneous clinical presentations which were not significantly different with comparable rates of fever (p=0.555), neurological symptoms (p=0.140), anemia (p=0.203) and thrombocytopenia (0.223). However, patients with detectable ADAMTS13 activity had higher rates of renal impairment at presentation (34% versus 72%, p=0.012) and higher mean serum creatinine at presentation (3.23±2.55 versus 1.94±2.21, p=0.009). Both groups of patients had similar rates of response to plasma exchange, mortality (p=0.620) and relapse (p=1.000). However patients with detectable ADAMTS13 activity had significantly worse renal outcomes than patients with severe deficiency with higher rates of acute renal failure needing dialysis [Relative Risk (RR) 2.89, 95% CI 1.66-5.05), progression to chronic renal insufficiency (RR 2.86, 95% CI 1.37-5.96) and end stage renal disease needing dialysis (RR 3.12, 95% CI 2.11-4.61). Conclusions Patients with and without severe ADAMTS13 deficiency have similar presenting features and clinical outcomes (mortality and relapse). Patients with detectable or normal ADAMTS13 activity have worse renal outcomes (acute renal failure, chronic renal insufficiency). At least some of these patients may have an alternative form of thrombotic microangiopathy such as atypical hemolytic uremic syndrome (aHUS) and may be candidates for earlier evaluation for aHUS and possible complement directed therapy. Disclosures: No relevant conflicts of interest to declare.


Renal Failure ◽  
1997 ◽  
Vol 19 (2) ◽  
pp. 279-282 ◽  
Author(s):  
Yvoty A. S. Sens ◽  
Luiz A. Miorin ◽  
HÉLio G. C. Silva ◽  
Denise M.A.C Malheiros ◽  
Dino M. Filho ◽  
...  

1998 ◽  
Vol 31 (11) ◽  
pp. 1405-1409
Author(s):  
Shigeo Negi ◽  
Masanori Okamoto ◽  
Hirohito Hasegawa ◽  
Seiji Ohashi ◽  
Hirotsugu Kobata ◽  
...  

Lupus ◽  
2016 ◽  
Vol 26 (7) ◽  
pp. 777-782 ◽  
Author(s):  
X-J Zhou ◽  
M Chen ◽  
S-X Wang ◽  
F-D Zhou ◽  
M-H Zhao

Background Microvascular manifestations of antiphospholipid antibody syndrome in the kidneys include acute renal failure, thrombotic microangiopathy and hypertension. Therapy has been largely empiric. Case report A 49-year-old Chinese man presented with anuric acute renal failure without abundant proteinuria and heavy haematuria, but markedly low levels of urinary sodium, potassium and chlorine upon admission. On day 1 of hospitalization, his thrombocytopenia, anaemia and renal failure showed rapid progression. The presence of lupus anticoagulant and vascular ischaemia of the small vessels in renal arteriography were also observed. Anticoagulants, continuous renal replacement therapy, glucocorticoids and six sessions of plasma exchange were started. After the fourth plasma exchange (on day 20), his urine output increased and began to normalize. On day 25, haemodialysis was stopped and his general condition gradually improved. A renal biopsy was subsequently performed, and the histopathological diagnosis was thrombotic microangiopathy due to antiphospholipid antibody syndrome. A further 3-year follow-up showed that his haemoglobin level, platelet count and serum creatinine were within the normal range, with stable blood pressure. Conclusion Treatment modalities such as anticoagulation, immunosuppression and plasma exchange are likely to be necessary when severe acute renal failure combined with thrombotic microangiopathy present in nephropathy of antiphospholipid antibody syndrome.


Nephron ◽  
1988 ◽  
Vol 50 (2) ◽  
pp. 167-168 ◽  
Author(s):  
F. Conte ◽  
M. Meroni ◽  
G. Battini ◽  
G. Ferrario ◽  
A. Tommasi ◽  
...  

2005 ◽  
Vol 10 (20) ◽  
Author(s):  
Kevin Pollock

Previous surveillance of childhood haemolytic uraemic syndrome (HUS) in Scotland has identified Escherichia coli O157 in over 90% of cases, and infection with E. coli O157 is now reported to be one of the major causes of acute renal failure in children


Sign in / Sign up

Export Citation Format

Share Document